Cetera Investment Advisers’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $311K | Sell |
2,031
-1,063
| -34% | -$163K | ﹤0.01% | 3361 |
|
|
2025
Q1 | $487K | Buy |
3,094
+423
| +16% | +$66.6K | ﹤0.01% | 2858 |
|
|
2024
Q4 | $419K | Buy |
2,671
+404
| +18% | +$63.4K | ﹤0.01% | 2816 |
|
|
2024
Q3 | $402K | Buy |
2,267
+72
| +3% | +$12.8K | ﹤0.01% | 2837 |
|
|
2024
Q2 | $370K | Sell |
2,195
-3,561
| -62% | -$600K | ﹤0.01% | 2839 |
|
|
2024
Q1 | $957K | Buy |
+5,756
| New | +$957K | ﹤0.01% | 2104 |
|
|
2023
Q2 | – | Sell |
-2,500
| Closed | -$405K | – | 2185 |
|
|
2023
Q1 | $405K | Sell |
2,500
-70
| -3% | -$11.3K | ﹤0.01% | 1542 |
|
|
2022
Q4 | $411K | Buy |
+2,570
| New | +$411K | ﹤0.01% | 1482 |
|
|
2022
Q3 | – | Sell |
-2,726
| Closed | -$397K | – | 1732 |
|
|
2022
Q2 | $397K | Sell |
2,726
-2,230
| -45% | -$325K | 0.01% | 1239 |
|
|
2022
Q1 | $804K | Sell |
4,956
-1,418
| -22% | -$230K | 0.01% | 897 |
|
|
2021
Q4 | $1.21M | Buy |
6,374
+16
| +0.3% | +$3.03K | 0.02% | 741 |
|
|
2021
Q3 | $1.29M | Buy |
6,358
+3,596
| +130% | +$727K | 0.02% | 687 |
|
|
2021
Q2 | $557K | Sell |
2,762
-710
| -20% | -$143K | 0.01% | 1064 |
|
|
2021
Q1 | $609K | Sell |
3,472
-22
| -0.6% | -$3.86K | 0.01% | 871 |
|
|
2020
Q4 | $593K | Buy |
+3,494
| New | +$593K | 0.01% | 884 |
|